Thomas Jefferson University Research Magazine



Combination antiretroviral therapy (ART) has turned HIV infection into a treatable, chronic condition, rather than one that is almost inevitably fatal. As a result, as they age, people with HIV often begin taking other medications to treat medical conditions ranging from heart disease to gastrointestinal problems to cancer. The increased number of medications creates a risk for drug-drug interactions. Jason Schafer, PharmD, professor and vice chair of pharmacy practice, is exploring combinations of ART drugs that can reduce the number and severity of those interactions.